Corinne Staner

670 total citations
12 papers, 508 citations indexed

About

Corinne Staner is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Endocrine and Autonomic Systems. According to data from OpenAlex, Corinne Staner has authored 12 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cognitive Neuroscience, 7 papers in Experimental and Cognitive Psychology and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Corinne Staner's work include Sleep and related disorders (7 papers), Sleep and Wakefulness Research (7 papers) and Circadian rhythm and melatonin (6 papers). Corinne Staner is often cited by papers focused on Sleep and related disorders (7 papers), Sleep and Wakefulness Research (7 papers) and Circadian rhythm and melatonin (6 papers). Corinne Staner collaborates with scholars based in France, United States and Israel. Corinne Staner's co-authors include Luc Staner, R. Luthringer, Geert Mayer, Barbara F. Roth‐Schechter, Markku Partinen, R. Lehmann, Jay Saoud, Sarah Otmani, Tali Nir and A. Demazières and has published in prestigious journals such as American Journal of Psychiatry, Journal of Hepatology and Schizophrenia Bulletin.

In The Last Decade

Corinne Staner

12 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corinne Staner France 11 301 300 194 130 69 12 508
Sylvie Chouinard Canada 9 189 0.6× 254 0.8× 48 0.2× 149 1.1× 65 0.9× 14 431
Janek Spada Germany 13 191 0.6× 196 0.7× 70 0.4× 95 0.7× 22 0.3× 16 362
Niki Boggs United States 10 249 0.8× 146 0.5× 39 0.2× 65 0.5× 110 1.6× 10 489
Lourdes Galicia-Polo Mexico 8 146 0.5× 177 0.6× 64 0.3× 43 0.3× 85 1.2× 12 316
D Schneider-Helmert Switzerland 12 346 1.1× 338 1.1× 106 0.5× 77 0.6× 15 0.2× 32 508
Zara de Saint Hilaire France 10 171 0.6× 228 0.8× 157 0.8× 49 0.4× 45 0.7× 16 395
Kerry Budd United States 5 482 1.6× 512 1.7× 347 1.8× 42 0.3× 12 0.2× 9 627
Karolina Furczyk Germany 5 72 0.2× 86 0.3× 104 0.5× 88 0.7× 35 0.5× 7 308
Jue Huang Germany 12 175 0.6× 257 0.9× 21 0.1× 236 1.8× 28 0.4× 27 498
Brenda Mc Mahon Denmark 10 89 0.3× 96 0.3× 75 0.4× 42 0.3× 37 0.5× 15 333

Countries citing papers authored by Corinne Staner

Since Specialization
Citations

This map shows the geographic impact of Corinne Staner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinne Staner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinne Staner more than expected).

Fields of papers citing papers by Corinne Staner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinne Staner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinne Staner. The network helps show where Corinne Staner may publish in the future.

Co-authorship network of co-authors of Corinne Staner

This figure shows the co-authorship network connecting the top 25 collaborators of Corinne Staner. A scholar is included among the top collaborators of Corinne Staner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinne Staner. Corinne Staner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rabinowitz, Jonathan, Corinne Staner, Jay Saoud, et al.. (2023). Long-term effects of Roluperidone on negative symptoms of schizophrenia. Schizophrenia Research. 255. 9–13. 12 indexed citations
2.
Davidson, Michael, Jay Saoud, Corinne Staner, et al.. (2022). Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia. Schizophrenia Bulletin. 48(3). 609–619. 45 indexed citations
3.
Keefe, Richard S.E., Philip D. Harvey, Anzalee Khan, et al.. (2018). Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms. The Journal of Clinical Psychiatry. 79(3). 25 indexed citations
4.
Davidson, Michael, Jay Saoud, Corinne Staner, et al.. (2017). Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. American Journal of Psychiatry. 174(12). 1195–1202. 74 indexed citations
5.
Joly, Sandrine, Jacky Vonderscher, Patrice André, et al.. (2017). The selective FXR agonist EYP001 is well tolerated in healthy subjects and has additive anti-HBV effect with nucleoside analogues in HepaRG cells. Journal of Hepatology. 66(1). S690–S690. 11 indexed citations
6.
Greenblatt, David J., Jerold S. Harmatz, James K. Walsh, et al.. (2011). Pharmacokinetic profile of SKP‐1041, a modified release formulation of zaleplon. Biopharmaceutics & Drug Disposition. 32(9). 489–497. 2 indexed citations
7.
Staner, Corinne, et al.. (2010). Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia. Current Medical Research and Opinion. 26(6). 1423–1431. 12 indexed citations
8.
Mayer, Geert, et al.. (2009). Efficacy and Safety of 6-Month Nightly Ramelteon Administration in Adults with Chronic Primary Insomnia. SLEEP. 32(3). 351–360. 104 indexed citations
9.
Otmani, Sarah, A. Demazières, Corinne Staner, et al.. (2008). Effects of prolonged‐release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Human Psychopharmacology Clinical and Experimental. 23(8). 693–705. 99 indexed citations
10.
Deacon, Steve, et al.. (2007). Effect of Short-term Treatment With Gaboxadol on Sleep Maintenance and Initiation in Patients With Primary Insomnia. SLEEP. 30(3). 281–287. 38 indexed citations
11.
Lundahl, Jonas, Luc Staner, Corinne Staner, Henrik Loft, & Steve Deacon. (2007). Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology. 195(1). 139–146. 24 indexed citations
12.
Staner, Luc, Olivier Le Bon, Corinne Staner, et al.. (2003). Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia. Journal of Sleep Research. 12(4). 319–330. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026